Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value (euro) 0.01 per share
-
Shares outstanding
-
121M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
93.1M
-
Shares change
-
+1.7M
-
Total reported value, excl. options
-
$501M
-
Value change
-
+$13.4M
-
Put/Call ratio
-
0
-
Number of buys
-
40
-
Number of sells
-
-40
-
Price
-
$5.38
Significant Holders of Immatics N.V. - Ordinary Shares, nominal value (euro) 0.01 per share (IMTX) as of Q2 2025
96 filings reported holding IMTX - Immatics N.V. - Ordinary Shares, nominal value (euro) 0.01 per share as of Q2 2025.
Immatics N.V. - Ordinary Shares, nominal value (euro) 0.01 per share (IMTX) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.1M shares
of 121M outstanding shares and own 77.1% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (18.3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (12M shares), BAKER BROS. ADVISORS LP (10.2M shares), PERCEPTIVE ADVISORS LLC (9.38M shares), RTW INVESTMENTS, LP (6.97M shares), Vestal Point Capital, LP (6.25M shares), WELLINGTON MANAGEMENT GROUP LLP (5.32M shares), Woodline Partners LP (3.88M shares), Paradigm Biocapital Advisors LP (3.14M shares), and TORONTO DOMINION BANK (2.91M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.